{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:07:55Z","timestamp":1790683675027,"version":"4.1.0"},"reference-count":60,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"607","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA217251"],"award-info":[{"award-number":["CA217251"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA221957"],"award-info":[{"award-number":["CA221957"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex\u2019s Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP170510"],"award-info":[{"award-number":["RP170510"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FUNDING"},{"DOI":"10.13039\/501100002795","name":"CANDU Owners Group","doi-asserted-by":"publisher","award":["RP170510"],"award-info":[{"award-number":["RP170510"]}],"id":[{"id":"10.13039\/501100002795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2021,8,18]]},"abstract":"<jats:p>ATM activation at telomeres confers chemoresistance in ALT neuroblastoma and is reversible in preclinical models by ATM knockdown or inhibition.<\/jats:p>","DOI":"10.1126\/scitranslmed.abd5750","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T15:10:26Z","timestamp":1629299426000},"source":"Crossref","is-referenced-by-count":55,"title":["ALT neuroblastoma chemoresistance due to telomere dysfunction\u2013induced ATM activation is reversible with ATM inhibitor AZD0156"],"prefix":"10.1126","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-7049","authenticated-orcid":true,"given":"Balakrishna","family":"Koneru","sequence":"first","affiliation":[{"name":"Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."},{"name":"Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."},{"name":"Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9605-7113","authenticated-orcid":true,"given":"Ahsan","family":"Farooqi","sequence":"additional","affiliation":[{"name":"Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6660-6556","authenticated-orcid":true,"given":"Thinh H.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-883X","authenticated-orcid":true,"given":"Wan Hsi","family":"Chen","sequence":"additional","affiliation":[{"name":"Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashly","family":"Hindle","sequence":"additional","affiliation":[{"name":"Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."},{"name":"Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-0841","authenticated-orcid":true,"given":"Cody","family":"Eslinger","sequence":"additional","affiliation":[{"name":"Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4068-7375","authenticated-orcid":true,"given":"Monish Ram","family":"Makena","sequence":"additional","affiliation":[{"name":"Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor A.","family":"Burrow","sequence":"additional","affiliation":[{"name":"Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3778-1918","authenticated-orcid":true,"given":"Joanne","family":"Wilson","sequence":"additional","affiliation":[{"name":"Early Oncology, R&amp;D AstraZeneca, Cambridge CB10 1XL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3768-8550","authenticated-orcid":true,"given":"Aaron","family":"Smith","sequence":"additional","affiliation":[{"name":"Early Oncology, R&amp;D AstraZeneca, Cambridge CB10 1XL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7786-4371","authenticated-orcid":true,"given":"Venkatesh","family":"Pilla Reddy","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Quantitative Pharmacology, Biopharmaceuticals R&amp;D, AstraZeneca, Cambridge SG8 6EE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9757-8305","authenticated-orcid":true,"given":"Elaine","family":"Cadogan","sequence":"additional","affiliation":[{"name":"Early Oncology, R&amp;D AstraZeneca, Cambridge CB10 1XL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-7499","authenticated-orcid":true,"given":"Stephen T.","family":"Durant","sequence":"additional","affiliation":[{"name":"Early Oncology, R&amp;D AstraZeneca, Cambridge CB10 1XL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2827-8536","authenticated-orcid":true,"given":"C. Patrick","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."},{"name":"Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."},{"name":"Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."},{"name":"Department of Internal Medicine, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7605428"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.06.018"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.06.009"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/82586"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-4035"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb00098.x"},{"key":"e_1_3_3_9_2","first-page":"4175","article-title":"Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body","volume":"59","author":"Yeager T. R.","year":"1999","unstructured":"T. R. Yeager, A. A. Neumann, A. Englezou, L. I. Huschtscha, J. R. Noble, R. R. Reddel, Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175\u20134179 (1999).","journal-title":"Cancer Res."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1587"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature20099"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201643169"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00226-17"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1257216"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00186"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01582-2"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10180-6"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08905-8"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.222349"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx061"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.05.087"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.05.046"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28748"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.0421"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804577"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.11642"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0911123"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat6768"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00072","article-title":"Telomerase is a prognostic marker of poor outcome and a therapeutic target in neuroblastoma","volume":"3","author":"Roderwieser A.","year":"2019","unstructured":"A. Roderwieser, F. Sand, E. Walter, J. Fischer, J. Gecht, C. Bartenhagen, S. Ackermann, F. Otte, A. Welte, Y. Kahlert, D. Lieberz, F. Hertwig, H. C. Reinhardt, T. Simon, M. Peifer, M. Ortmann, R. B\u00fcttner, B. Hero, R. J. O\u2019Sullivan, F. Berthold, M. Fischer, Telomerase is a prognostic marker of poor outcome and a therapeutic target in neuroblastoma. JCO Precis. Oncol. 3, 1\u201320 (2019).","journal-title":"JCO Precis. Oncol."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-3068"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.228"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10910"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2014.09.029"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12681-5"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1078-0432.217.11.1","article-title":"A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas","volume":"11","author":"Henson J. D.","year":"2005","unstructured":"J. D. Henson, J. A. Hannay, S. W. McCarthy, J. A. Royds, T. R. Yeager, R. A. Robinson, S. B. Wharton, D. A. Jellinek, S. M. Arbuckle, J. Yoo, B. G. Robinson, D. L. Learoyd, P. D. Stalley, S. F. Bonar, D. Yu, R. E. Pollock, R. R. Reddel, A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin. Cancer Res. 11, 217\u2013225 (2005).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000324"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5424-8"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1147"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2009.07.046"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-014-1456-8"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1140321"},{"key":"e_1_3_3_42_2","first-page":"6185","article-title":"Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines","volume":"61","author":"Keshelava N.","year":"2001","unstructured":"N. Keshelava, J. J. Zuo, P. Chen, S. N. Waidyaratne, M. C. Luna, C. J. Gomer, T. J. Triche, C. P. Reynolds, Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res. 61, 6185\u20136193 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(03)00542-6"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06065"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1725"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1815309"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80932-0"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.10.008"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01896"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.09.002"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2012.11.006"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0910"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-0385"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001020"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605927"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21078"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22801"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0749"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2013.12.020"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00300234"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.09.071"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1126\/scitranslmed.abd5750","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.abd5750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T11:57:25Z","timestamp":1705406245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.abd5750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":60,"journal-issue":{"issue":"607","published-print":{"date-parts":[[2021,8,18]]}},"alternative-id":["10.1126\/scitranslmed.abd5750"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.abd5750","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.06.438692","asserted-by":"object"}]},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"article-number":"eabd5750"}}